OOIR: Observatory of International Research

Papers

(The H4-Index of Clinical Research in Cardiology is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Symptomatic vs. non-symptomatic device-related thrombus after LAAC: a sub-analysis from the multicenter EUROC-DRT registry	89
Ferritin, inflammation, and iron deficiency in acute heart failure: evidence from the EDIFICA cohort	74
Trans-fatty acid blood levels of industrial but not natural origin are associated with cardiovascular risk factors in patients with HFpEF: a secondary analysis of the Aldo-DHF trial	62
Prognostic value of high-sensitivity cardiac troponin I after isolated non-CABG cardiac surgery	61
Changes in numbers needed to treat and hospital care expenditures of optimized indications for primary prevention implantable cardioverter defibrillators: a scenario analysis	57
HI-PLUS: design of a cluster-randomized trial evaluating structured case management with telemonitoring to improve quality of life in heart failure	52
10-year follow-up of interventional electrophysiology: updated German survey during the COVID-19 pandemic	49
Prognosis of cardiogenic shock with and without acute myocardial infarction: results from a prospective, monocentric registry	47
Biventricular impella (BiPella) utilization in fulminant COVID-19 myopericarditis-mediated cardiogenic shock during pregnancy	47
Perioperative atrial fibrillation after non-cardiac surgery — A narrative review	45
Simultaneous transcatheter valve-in-valve replacement of severely degenerated bioprosthetic aortic and mitral prostheses	42
Association of daily physical activity with pulmonary artery pressure in HFpEF and HFmrEF NYHA class III patients: a pilot trial—feasibility and first results	40
Collagen type I degradation peptide as a predictive biomarker for mortality in ST-elevated myocardial infarction	39
Rebuttal to: “Comment on the CORRECT RADIAL trial: considerations on methodology and interpretation.“ (CRCD-D-26–00099)	39
Protective effect of vaccination on the risk of cardiovascular disease after SARS-CoV-2 infection	38
Efficacy of coronary sinus reducer in patients with refractory angina and chronic total occlusion	37
Prognostic utility of a multi-biomarker panel in patients with suspected myocardial infarction	34
Correlation of greyzone fibrosis compared to troponin T and late gadolinium enhancement with survival and ejection fraction in patients after acute myocardial infarction	33
Ventilation strategies in cardiogenic shock: insights from the FRENSHOCK observational registry	31
Heart failure burden and care among cardiology inpatients: insights from the Hellenic Cardiorenal Morbidity Snapshot (HECMOS) study	30
Not obtaining a medication the first time it is prescribed: primary non-adherence to cardiovascular pharmacotherapy	29
Venting during venoarterial extracorporeal membrane oxygenation	27
Clinical characteristics and etiology-specific outcome in pediatric hypertrophic cardiomyopathy	27
Appointment as Editor-in-Chief of Clinical Research in Cardiology—goals and vision	26
Echocardiographic assessment of left ventricular volumes: a comparison of different methods in athletes	26

Left ventricular ejection fraction determines the pattern of left atrial remodeling in patients with heart failure without atrial fibrillation